News Roundup- Amgen (NASDAQ:AMGN), Cooper Tire & Rubber (NYSE:CTB), Fluor (NYSE:FLR), PDL BioPharma (NASDAQ:PDLI) | The Cinema Post
Thursday , September 20 2018
Home / Business News / News Roundup- Amgen (NASDAQ:AMGN), Cooper Tire & Rubber (NYSE:CTB), Fluor (NYSE:FLR), PDL BioPharma (NASDAQ:PDLI)

News Roundup- Amgen (NASDAQ:AMGN), Cooper Tire & Rubber (NYSE:CTB), Fluor (NYSE:FLR), PDL BioPharma (NASDAQ:PDLI)

Amgen, Inc. (NASDAQ:AMGN) (Read Latest Free Analytic Facts on AMGN and Be Updated) released that its Phase 3 study evaluating efficacy along with safety of biosimilar candidate ABP 501 compared with Humira in patients with moderate-to-severe plaque psoriasis met its primary endpoint. Whereas, shares of Amgen, Inc. (NASDAQ:AMGN) traded up of 2.97% to finished at USD140.07 with market capitalization of 103.33 billion. Separately, a research note to investors, 11 analysts rates its stocks at “Hold,” 3 analysts rate it at “strong buy” and 9 rate it a “Buy.”

Cooper Tire & Rubber Co (NYSE:CTB) (Get Free Highly Paid Dividend Stocks Reports) reported that it has got notice and related documentation from Chengshan Group Company Ltd. that it intends to exercise its option to acquire Cooper’s 65% ownership stake in Cooper Chengshan (Shandong) Tire Company Ltd. Cooper Tire & Rubber Co (NYSE:CTB) stock fell of -2.42% to closed at $28.60 with the total traded volume of 1.59 million shares. The consensus average revenue estimates are $910.33M for latest quarter, at the same time as 5 experts predict $880.70M revenues for the next three months of 2014.

Fluor Corporation (NEW) (NYSE:FLR) (Read Report! How FLR Noticeable Reacts on News Jerk?) reported that it was awarded a construction agreement by American Electric Power (AEP) to provide environmental retrofit services at the utility company’s Northeastern power station in Oologah, Oklahoma. Fluor Corporation (NEW) (NYSE:FLR) saw as a gainer stock in last session, rose 2.10% to finished at $65.27 with the overall traded volume of 2.22 million shares. The street professionals’ recommendation trends reflect as, stock on “Buy” rating by 12 analysts, while 3 analysts rate its shares as a “hold” security.

PDL BioPharma Inc (NASDAQ:PDLI) (Get Visual Access about Inside Factors Trade Here) reported that the retirement of Assurant Employee Benefits President and CEO John Roberts in January 2015. Adam Lamnin, president and CEO of Assurant Health, will assume the additional executive leadership responsibilities for Assurant Employee Benefits, effective January 1, 2015. PDL BioPharma Inc (NASDAQ:PDLI) (Get Visual Access about Inside Factors Trade Here) after opening at $7.44 hit its day high price of $7.73 moreover rose 4.75% to closed at $7.72. The consensus average revenue estimates are $164.73M for latest quarter, at the same time as 3 experts predict $169.77B revenues for the next three months of 2014.

For latest Market Updates Subscribes Here

Facebook Comments